Dr. James Michael Orcutt, MD
- Medicare services, 2023
- 1,104
- Part D claims, 2024
- 214
- Publications
- 3
- Clinical trials
- 5
- Hospital affiliations
- 1
- Practice address
- 2095 Henry Tecklenburg Drive, Charleston, SC 29414
- Practice phone
- Call (843) 402-1006
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Orcutt's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. James Michael Orcutt is a hematologist and oncologist in Charleston, South Carolina
Dr. Orcutt practices at Bon Secours St. Francis Hospital in Charleston, South Carolina, part of Bon Secours Mercy Health.
Dr. Orcutt's NPI, 1336107424, was assigned on May 1, 2006. Dr. Orcutt graduated from Wake Forest University School of Medicine in 1990. Dr. Orcutt holds South Carolina license 18866.
- NPI
- 1336107424NPI Registry (opens in a new tab)
- NPI enumeration date
- May 1, 2006
- NPI status
- Active
- Practice phone
- (843) 402-1006
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 62
- Medical school graduation
- 1990
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. James Michael Orcutt practices at Bon Secours St. Francis Hospital in Charleston, South Carolina
Dr. Orcutt's primary practice is Bon Secours St. Francis Hospital, at 2095 Henry Tecklenburg Drive, Charleston, SC 29414 in Charleston County. The practice phone is (843) 402-1006.
- Bon Secours St. Francis Hospital2095 Henry Tecklenburg Drive, Charleston, SC 29414 · Charleston CountyPhone(843) 402-1006
Source: Dmand AI Affiliation Data
Dr. James Michael Orcutt is affiliated with 4 sites of care and 3 medical groups
Dr. Orcutt's primary practice is Bon Secours St. Francis Hospital in Charleston, South Carolina, part of Bon Secours Mercy Health. The medical group on file is Bon Secours St. Francis Hospital. Dmand AI also links Dr. Orcutt to 3 more group practices and clinics and 2 medical groups, each named with a free account. Dr. Orcutt's employer is on file too: a hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. James Michael Orcutt's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Orcutt practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Bon Secours St. Francis Hospital | Available with a free account |
| +3 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Bon Secours Mercy Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. James Michael Orcutt is one of 157 hematologists and oncologists in South Carolina
Hematology and oncology is Dr. Orcutt's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Orcutt is licensed in South Carolina.
Specialties and state licenses
- Hematology and oncology, South CarolinaPrimary
Hematologists and oncologists near Dr. Orcutt
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. James Michael Orcutt billed Medicare for 1,104 services in 2023
CMS data shows 1,104 Medicare services from Dr. Orcutt across 10 procedure codes in 2023. Medicare paid $99,261 for them.
Dr. Orcutt's Medicare services by type, 2022 to 2023
- 2022
- 2023
- Office and hospital visits
- 2022: 1,9302023: 1,10443%
- Drugs given in the office
- 2022: 26,5242023: 0100%
- Imaging
- 2022: 2562023: 0100%
- Lab and pathology
- 2022: 6,7102023: 0100%
- Tests and treatments
- 2022: 1,5142023: 0100%
- Other services
- 2022: 30,8632023: 0100%
- Surgery
- 2022: 1,8172023: 0100%
Where Dr. Orcutt's Medicare services took place, 2023
- In an office85377%
- In a facility25123%
Dr. Orcutt compared with the South Carolina median for hematologists and oncologists, 2023
- Dr. Orcutt
- South Carolina median
- Medicare services
- 1,104vs 1,53428% below
- Part D claims
- 102vs 68685% below
Medians across 160 hematologists and oncologists in South Carolina with Dmand AI profiles that report each measure.
Dr. Orcutt's most billed Medicare procedure codes, 2023
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Orcutt?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Orcutt and other hematologists and oncologists in South Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. James Michael Orcutt's patients have a median age of 74
Across all payers, Dmand AI patient panel data puts Dr. Orcutt's median patient age at 74, with 64% women.
Dr. Orcutt's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women64%
- Men36%
Source: Dmand AI Patient Panel Data
Dr. James Michael Orcutt wrote 214 Medicare Part D claims in 2024
In 2024, Dr. Orcutt wrote 214 Medicare Part D claims for 74 patients. 65% of them were for generic drugs. CMS names the drug for 102 of them, across 6 drugs with 11 or more claims each, at $544,042 in total drug cost. In 2023, CMS named 703 claims across 30 drugs.
Dr. Orcutt's Part D claims by kind of drug, 2024
- Generic140 claims65%
- Brand-name74 claims35%
Dr. Orcutt's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 7032024: 10285%
Drugs named by CMS: 6 in 2024, 30 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. James Michael Orcutt has 3 publications on record
Dmand AI links 3 papers to Dr. Orcutt, published from 2019 to 2020. 2019 was the busiest year, with 2. Dr. Orcutt's most frequent co-authors are Carmen Joseph Allegra, MD, Samuel A. Jacobs, MD and Ashok Srinivasan, MD.
Dr. Orcutt's most frequent co-authors
- Carmen Joseph Allegra, MD2 shared papers
- Samuel A. Jacobs, MD2 shared papers
- Ashok Srinivasan, MD2 shared papers
Recent publications by Dr. Orcutt
See who Dr. Orcutt researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Orcutt works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. James Michael Orcutt has worked on 5 clinical trials
Dmand AI links Dr. Orcutt to 5 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Triple Negative Breast Neoplasms and Breast Neoplasms, Male. SWOG Cancer Research Network sponsors the most, 2.
Clinical trials with Dr. Orcutt by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 3Phase 3: 3 trials
- NonePhase 4: no trials
Conditions in Dr. Orcutt's trials
- Breast Neoplasms
- Triple Negative Breast Neoplasms
- Breast Neoplasms, Male
- Lymphoma, Large B-Cell, Diffuse
- Prostatic Neoplasms
Investigators on the most trials with Dr. Orcutt
- Mitchell B. Alden, DO2 shared trials
- Ari D. Baron, MD2 shared trials
- Sam Benjamin, MD2 shared trials
Recent clinical trials with Dr. Orcutt
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL (opens in a new tab)
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (opens in a new tab)
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. James Michael Orcutt received $17,261 in industry payments from 2016 to 2025
CMS Open Payments shows 954 general payments to Dr. Orcutt from 73 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,016.
General payments to Dr. Orcutt by program year, 2016 to 2025
General payments to Dr. Orcutt by kind, 2016 to 2025
- Food and beverage$16,46195%
- Gifts$4653%
- Education$3342%
Companies that paid Dr. Orcutt the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. James Michael Orcutt graduated from Wake Forest University School of Medicine
Dr. Orcutt graduated from Wake Forest University School of Medicine in 1990.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. James Michael Orcutt's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. James Michael Orcutt
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. James Michael Orcutt's NPI number?
Dr. James Michael Orcutt's NPI number is 1336107424. It was assigned on May 1, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. James Michael Orcutt?
Dr. James Michael Orcutt is a hematologist and oncologist in Charleston, South Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. James Michael Orcutt practice?
Dr. Orcutt practices at 2095 Henry Tecklenburg Drive, Charleston, SC 29414. Dr. Orcutt's primary practice is Bon Secours St. Francis Hospital in Charleston, South Carolina, part of Bon Secours Mercy Health. Dmand AI also links Dr. Orcutt to 3 group practices and clinics and 2 medical groups.
What is Dr. James Michael Orcutt's office phone number?
The practice phone on file for Dr. Orcutt is (843) 402-1006.
What is Dr. James Michael Orcutt's medical license number?
Dr. Orcutt holds South Carolina license 18866.
Which hospitals is Dr. James Michael Orcutt affiliated with?
Dr. Orcutt practices at Bon Secours St. Francis Hospital in Charleston, South Carolina.
What medical group is Dr. James Michael Orcutt part of?
Dr. Orcutt is linked to Bon Secours St. Francis Hospital. Dmand AI links Dr. Orcutt to 2 more medical groups.
Does Dr. James Michael Orcutt accept Medicare?
Yes. CMS data shows Dr. Orcutt billed Medicare for 1,104 services in 2023.
What services does Dr. James Michael Orcutt bill to Medicare?
In 2023, Dr. Orcutt's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and hospital inpatient care (99232).
Where did Dr. James Michael Orcutt go to medical school?
Dr. Orcutt graduated from Wake Forest University School of Medicine in 1990.
Show 5 more questionsShow fewer questions
What drugs does Dr. James Michael Orcutt prescribe most?
In 2024 Medicare Part D data, Dr. Orcutt's most prescribed drugs by claims were Letrozole, Verzenio and Calquence.
Has Dr. James Michael Orcutt received payments from drug or device companies?
CMS Open Payments shows $17,261 in general payments to Dr. Orcutt from 73 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. James Michael Orcutt been practicing?
Dr. Orcutt graduated from medical school in 1990, 36 years ago.
Does Dr. James Michael Orcutt do research?
Dmand AI links 3 publications to Dr. Orcutt, published from 2019 to 2020. Dr. Orcutt has worked on 5 clinical trials.
Who does Dr. James Michael Orcutt publish with?
Dr. Orcutt's most frequent co-authors are Carmen Joseph Allegra, MD (2 shared papers), Samuel A. Jacobs, MD (2 shared papers) and Ashok Srinivasan, MD (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in South Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card